MasTec
MTZ
$375.09
-2.80%
MasTec, Inc. is a leading infrastructure construction company operating primarily in North America, providing engineering, building, installation, maintenance, and upgrade services for communications, oil and gas, utility, and renewable energy infrastructure. The company is a diversified player in the Engineering & Construction industry, leveraging its scale and expertise across five key segments to serve a broad range of critical infrastructure projects. The current investor narrative is heavily focused on the company's positioning as a key beneficiary of large-scale infrastructure spending, particularly in the clean energy and communications sectors, with recent financial results showing a strong recovery in profitability and revenue growth driving significant stock momentum.…
MTZ
MasTec
$375.09
Investment Opinion: Should I buy MTZ Today?
Rating: Hold. The core thesis is that MTZ is a high-quality turnaround story with powerful momentum, but its risk/reward profile is balanced at current levels due to a full valuation and high volatility, warranting patience for a better entry point. The Hold rating is supported by four key data points: 1) The stock trades at a premium trailing P/E of 42.4x, well above its historical norm, 2) Revenue growth is robust at 15.8% YoY and profitability is recovering, with operating margin hitting 5.3% in Q4, 3) The company generates positive free cash flow ($207.6M TTM), strengthening the balance sheet (D/E of 0.86), and 4) The PEG ratio of 0.29 suggests the growth-adjusted valuation is compelling, though this metric can be volatile. The two biggest risks that could invalidate this Hold thesis are a failure to meet the high earnings growth implied by the 34.5x forward P/E, and a sharp market correction exacerbated by the stock's 1.8 beta. This Hold would upgrade to a Buy if the stock experiences a healthy pullback to the $300-$320 range (compressing the forward P/E) while the fundamental growth story remains intact, or if Q1 2026 results show accelerating margins. It would downgrade to Sell if revenue growth decelerates below 10% or operating margins contract sequentially. Relative to its own history, the stock is overvalued, but relative to its growth trajectory (PEG), it appears fairly valued to slightly undervalued, creating the current balanced view.
Sign up to view all
MTZ 12-Month Price Forecast
The outlook for MTZ is a battle between a compelling fundamental growth story and a demanding valuation. The company's operational turnaround is undeniable, positioning it as a prime beneficiary of long-term infrastructure trends. However, the stock's meteoric rise has likely front-loaded much of this optimism, leaving limited margin for error. The neutral stance reflects this balance, with the base case (55% probability) expecting consolidation and volatility within a range. The stance would upgrade to bullish on a pullback that improves the risk/reward profile or evidence of sustained margin expansion above 6%. It would turn bearish on clear signs of growth deceleration or a breakdown below key technical support at $300.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MasTec's 12-month outlook, with a consensus price target around $487.62 and implied upside of +30.0% versus the current price.
Average Target
$487.62
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$300 - $488
Analyst target range
Insufficient analyst coverage data is available to provide a detailed consensus view, target price, or implied upside/downside. The provided data indicates only 4 analysts are providing estimates, which is limited coverage for a company of this market cap. This typically suggests MasTec may be under-followed by the broader institutional research community, which can lead to higher volatility and less efficient price discovery as news and quarterly results have an outsized impact. The lack of a consensus price target and a wide range of analyst estimates means there is high uncertainty regarding the stock's fair value. The provided institutional ratings show a uniformly bullish sentiment among the firms that do cover it, with recent actions from Jefferies, Mizuho, Citigroup, and others all maintaining Buy or Outperform ratings. However, without quantitative targets, it is difficult to gauge the magnitude of the expected upside these ratings imply. Investors should be aware that the stock's recent powerful rally has occurred with limited analyst guidance, making independent fundamental and valuation work particularly important.
Bulls vs Bears: MTZ Investment Factors
The bull case, centered on a powerful fundamental recovery and multi-year infrastructure tailwinds, currently holds stronger evidence, as demonstrated by the 15.8% revenue growth and dramatic margin expansion from losses to a 5.3% operating margin. However, the bear case presents a formidable counter-argument rooted in extreme valuation and high volatility. The single most important tension in the investment debate is whether the company's earnings growth can accelerate rapidly enough to justify and sustain its historically elevated P/E multiple of 42.4x, or if this premium will inevitably compress, triggering a significant drawdown from current levels.
Bullish
- Explosive Revenue & Profit Recovery: Q4 2025 revenue grew 15.8% YoY to $3.94B, demonstrating a powerful recovery from a weak Q1. More critically, net income surged to $142.7M in Q4 from a net loss in Q1 2024, with operating margin expanding to 5.28% from near-zero, proving the turnaround is fundamentally driven.
- Massive Technical Momentum & Outperformance: The stock has gained 206.2% over the past year, significantly outperforming the S&P 500 by 175.6%. Recent momentum remains strong with a 55.6% gain over three months, indicating sustained institutional and retail conviction in the infrastructure spending thesis.
- Strong Free Cash Flow & Healthy Leverage: The company generated $207.6M in TTM free cash flow and $372.7M in operating cash flow for Q4 2025. A debt-to-equity ratio of 0.86 and a current ratio of 1.32 indicate a manageable balance sheet, providing financial flexibility to fund growth.
- Attractive PEG Ratio Implies Growth Value: With a PEG ratio of 0.29, the stock appears undervalued relative to its expected earnings growth rate. This is based on a forward P/E of 34.5x and the implied growth from the company's dramatic earnings recovery trajectory.
Bearish
- Extreme Valuation Premium to History: The trailing P/E of 42.4x is at a significant premium to its historical range, which was often in the 20s and 30s. This leaves the stock vulnerable to valuation compression if earnings growth fails to meet the market's highly optimistic expectations.
- High Beta & Risk of Sharp Correction: With a beta of 1.8, MTZ is 80% more volatile than the market. Trading at 96% of its 52-week high after a 206% run, the stock is highly susceptible to a sentiment-driven correction, especially if broader market conditions deteriorate.
- Thin Analyst Coverage Creates Uncertainty: Only 4 analysts provide estimates, resulting in a lack of consensus price target and high uncertainty on fair value. This limited coverage can lead to inefficient price discovery and outsized reactions to quarterly results.
- Margin Volatility & Cyclical Pressures: While margins have recovered, they remain volatile; the Q4 2025 gross margin of 10.1% was down from 13.6% in Q3. As a cyclical infrastructure contractor, the company faces persistent pressure from labor, material costs, and project execution risks.
MTZ Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 206.21% gain over the past year. As of the latest close at $376.12, the price is trading near the top of its 52-week range, approximately 96% of the way from its low of $121.82 toward its high of $388.57, indicating strong momentum but also potential for overextension. The stock has significantly outperformed the broader market, with a relative strength of 175.62% over the past year, highlighting its status as a high-beta leader. Recent momentum remains exceptionally strong, with the stock up 16.25% over the past month and 55.55% over the past three months, both figures far exceeding the S&P 500's returns of 8.7% and 3.59%, respectively. This acceleration in the short-term gains, building upon the massive yearly move, suggests persistent and powerful buying pressure, though it also increases the risk of a sharp, sentiment-driven correction. The stock's beta of 1.8 confirms its high volatility, meaning it typically moves 80% more than the market, which is a critical factor for risk management. Key technical levels are clear, with immediate resistance at the 52-week high of $388.57 and support anchored at the 52-week low of $121.82, though more recent support has formed around the $300 level seen in March. A decisive breakout above the all-time high would signal a continuation of the powerful bull trend, while a breakdown below recent support could trigger a deeper correction. The high beta of 1.8 underscores that any market-wide volatility will be amplified in MTZ, necessitating careful position sizing for investors.
Beta
1.80
1.80x market volatility
Max Drawdown
-19.4%
Largest decline past year
52-Week Range
$122-$389
Price range past year
Annual Return
+197.3%
Cumulative gain past year
| Period | MTZ Return | S&P 500 |
|---|---|---|
| 1m | +18.7% | +12.2% |
| 3m | +53.3% | +2.3% |
| 6m | +75.3% | +4.7% |
| 1y | +197.3% | +29.2% |
| ytd | +64.8% | +4.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MTZ Fundamental Analysis
MasTec's revenue trajectory shows robust growth, with Q4 2025 revenue reaching $3.94 billion, representing a 15.77% year-over-year increase. This growth is being driven by its key segments; for the latest period, Clean Energy and Infrastructure was the largest contributor at $1.29 billion, followed by Communications at $906.7 million and Pipeline Infrastructure at $643.8 million. The sequential trend from a weak Q1 2025 ($2.85B revenue) to a strong Q4 demonstrates a significant operational recovery and acceleration throughout the fiscal year, underpinning the bullish investment case. Profitability has improved dramatically from a net loss in Q1 2024 to consistent profits. For Q4 2025, net income was $142.7 million, yielding a net margin of 3.62%, while the gross margin for the quarter was 10.08%. Margins have expanded notably from the depressed levels of early 2024; for instance, the operating margin in Q4 2025 was 5.28%, a substantial recovery from 0.01% in Q1 2024. This margin expansion, coupled with the return to profitability, is a central pillar of the fundamental story. The balance sheet and cash flow position appear healthy. The company generated $207.6 million in trailing twelve-month free cash flow and reported an operating cash flow of $372.7 million for Q4 2025. Financial leverage is moderate with a debt-to-equity ratio of 0.86, and liquidity is adequate with a current ratio of 1.32. The return on equity of 12.24% indicates decent efficiency in generating profits from shareholder capital. The positive free cash flow generation provides the company with internal funding flexibility for its capital-intensive projects.
Quarterly Revenue
$3.9B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.10%
Latest Quarter
Free Cash Flow
$207610000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MTZ Overvalued?
Given that MasTec is profitable with positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 42.42x and a forward P/E of 34.52x based on analyst estimates. The lower forward multiple implies the market expects significant earnings growth, which aligns with the company's recovery trajectory and analyst EPS estimates averaging $19.43 for the coming period. Compared to its own historical valuation, the current trailing P/E of 42.42x is notably elevated. It sits well above the P/E ratios seen throughout much of 2024 and early 2025, which were often in the 20s and 30s, and is a stark contrast to periods of losses where the P/E was negative. Trading near the top of its historical valuation band suggests the market is pricing in a highly optimistic outlook for sustained earnings growth and margin expansion, leaving little room for disappointment. Peer comparison data for the Engineering & Construction industry is not available in the provided dataset, preventing a direct sector premium/discount analysis. Therefore, the valuation assessment must rely on the stock's own historical context and the growth implied by the forward P/E. The current premium to its own history needs to be justified by the continuation of its strong fundamental turnaround and execution on large infrastructure project backlogs.
PE
42.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -46x~1958x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, the primary risk is valuation compression given the stock trades at a trailing P/E of 42.4x, a premium to its own history. While profitability has recovered, net margins remain thin at 3.6% in Q4 2025, indicating high operational leverage and sensitivity to cost overruns. The company's growth-dependent valuation means any deceleration from the current 15.8% revenue growth rate could disproportionately impact the stock price, as the forward P/E of 34.5x already embeds high expectations. Competitively and in the market, the stock's high beta of 1.8 exposes it to amplified downside during market corrections. Trading at 96% of its 52-week high after a 206% rally, it faces significant technical overextension and profit-taking risk. As a beneficiary of infrastructure spending, the stock is also subject to political and regulatory risk regarding the timing and allocation of public funds, which could delay project backlogs and impact future revenue visibility. The worst-case scenario involves a combination of a broader market downturn, a quarterly earnings miss that breaks the growth narrative, and subsequent multiple compression. This could trigger a rapid unwind of momentum-driven positions. A realistic downside could see the stock retreat towards its more established support level around $300 (a -20% decline from $376) or, in a severe bear market, test its 52-week low of $121.82, representing a catastrophic -68% loss. A more probable adverse scenario would be a -30% to -40% correction to the $225-$265 range, aligning with prior consolidation zones and a re-rating to a more historical P/E in the mid-20s.
FAQ
The key risks are, in order of severity: 1) Valuation Risk: The stock's premium P/E of 42.4x is vulnerable to compression if growth slows. 2) Volatility Risk: With a beta of 1.8, MTZ will fall significantly more than the market in a downturn. 3) Execution Risk: As a project-based business, cost overruns or delays could pressure thin margins (Q4 net margin 3.6%). 4) Macro/Political Risk: The company's growth is tied to infrastructure spending, which can be delayed by political processes or economic recessions.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $340 and $390, as it digests its massive gains and grows earnings in line with estimates. The Bull Case (25% probability) targets $400 to $450, driven by earnings beats and sustained momentum. The Bear Case (20% probability) warns of a correction to $250-$300 on a growth scare or market downturn. The most likely outcome is the Base Case, which assumes the company executes well but the stock's multiple does not expand further from current elevated levels.
MTZ appears overvalued on an absolute historical basis, trading at a trailing P/E of 42.4x, which is well above its historical range. However, on a growth-adjusted basis, the PEG ratio of 0.29 suggests it is undervalued, assuming its earnings growth continues apace. This dichotomy means the market is paying a premium price but for what it expects to be premium growth. The valuation implies the market expects the company's dramatic profit recovery (from losses to a 5.3% operating margin) to continue and accelerate, justifying the high multiple. If growth meets these high expectations, the stock is fairly valued; if not, it is overvalued.
MTZ is a compelling but high-risk investment at its current price. For investors who already believe in the multi-year infrastructure spending thesis and have a high tolerance for volatility, it offers direct exposure. However, after a 206% gain in one year and trading at a premium P/E of 42.4x, the stock's risk/reward is balanced, making it less attractive for new money. It would be a 'good buy' on a significant pullback (e.g., to the $300-$320 range) for long-term holders, but chasing the momentum here carries substantial risk of a sharp correction.
MTZ is more suitable for a medium- to long-term investment horizon of 2-3 years, not short-term trading. Its high beta of 1.8 makes it far too volatile for most short-term traders. The investment thesis is based on a multi-year infrastructure cycle, requiring time for projects to be awarded, executed, and reflected in earnings. The company does not pay a dividend, so the total return is dependent entirely on capital appreciation from growth. Investors should be prepared to withstand significant volatility along the way, making a longer holding period essential to realizing the potential of the underlying growth story.
